• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1996 Fiscal Year Final Research Report Summary

Activated Leukocyte-Endothelium Interactions during Ischemia Cause Endothelial Dysfunction on Reperfusion.

Research Project

Project/Area Number 07671460
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Thoracic surgery
Research InstitutionMie University

Principal Investigator

ONODA Koji  Mie University, Hospital, Assistant, 医学部・附属病院, 助手 (70260601)

Co-Investigator(Kenkyū-buntansha) YADA Isao  Mie University Faculty of Medicine, Professor, 医学部, 教授 (80093152)
Project Period (FY) 1995 – 1996
KeywordsREPERFUSION INJURY / ADHESION MOLECULE / ENDOTHELIAL CELL / NEUTROPHIL / MONOCLONAL ANTIBODY
Research Abstract

Background. Injury due to reperfusion of ischemic heart or lung is mediated by leukocyte-endothelial cell interactions, dependent on the integrin CDl1b, CDl8, and its endothelial cell ligand intercellular adhesion molecule. We studied these interactions and tried to mitigate this injury with monoclonal antibodies directed against the integrins.
Methods. The damage to endothelial cells exposed to ischemia and reperfusion was estimated by assessing the maximum relaxation rate of rat aortic or human pulmonary artery smooth muscle induced by endothelium-derived relaxing factor in the following groups. Group Ia : control. Group IIa : bovine leukocytes activated by PMA incubated with hypoxic bovine aortic endothelial cells (BEC). Group IIIa : bovine leikocytes activated by PMA which received monoclonal antibodies (MoAb) against CDl1b incubated with BEC.Group IVa : bovine leikocytes activated by PMA which received monoclonal antibodies (MoAb) against CDl8 incubated with BEC.Human pulmonary artery smooth muscle, human pulmonary artery endothelial cells in group Ib, IIb, IIIb, and IVb under similar conditions.
Results. The maximum relaxation rate of bovine smooth muscle was 51.5<plus-minus>2.4% in group Ia. The rates in groups IIIa and IVa (24.1<plus-minus>3.7% and 20.8<plus-minus>2.5%) were significantly greater than in group IIa (8.9<plus-minus>1.3%, p<0.05). Futhermore, the maximum relaxation rate of human smooth muscle was 50.3<plus-minus>2.0% in group Ib. The rates in groups IIIb and IVb (40.9<plus-minus>1.0% and 41.8<plus-minus>1.7%) were significantly greater than in group IIb (19.7<plus-minus
Conclusions. Antibodies against CDl1b and CDl8 prevent reperfusion-induced lung injury mediated by neutrophil-endothelial cell interactions.

  • Research Products

    (6 results)

All Other

All Publications (6 results)

  • [Publications] Yoshihiko Katayawa: "Effects of Inhaled Nitric Oxide in Single Loug Trous plantotion in Rats with heicocrtaline-induced Paluanany Hyperteusion." The Jourpnal of Heant and Lung Traneplantation. 14. 486-492 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 島本 亮: "体外質環下開心術における可溶性接着分子の変動とFUT-175の効果" 人工臓器. 25. 361-364 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 天白宏典: "微小管の形態変化と心機能からみたterninal wam cardioplegiaの効果" 心筋の構造と代謝. 18. 133-137 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yoshihiko Katayama et al.: "Effects of Inhaled Nitric Oxide in Single Lung Transplantation in Rats with Monocrotaline-induced Pulmonary Hypertension" J.Heart Lung Transplant. 14. 486-492 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Akira Shimamoto et al: "Effects of FUT-175 on postoperative organ dysfunction following open heart surgery with cardiopulmonary bypass (with special reference to soluble adhension molecules)." Jpn.J.Artif.Organs. 25. 361-364 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hironori Tenpaku et al.: "The effect of terminal warm cardioplegia on morphological changes of microtubules and cardiac function." Shinzou no Kouzou to Taisha. 18. 133-137 (1996)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1999-03-09  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi